| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/02/2001 | CN1293671A Substituted bisindolymaleimides for inhibition of cell proliferation |
| 05/02/2001 | CN1293663A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamix acids as matrix metal-protease |
| 05/02/2001 | CN1293662A Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 05/02/2001 | CN1293656A Anti-tumour agents |
| 05/02/2001 | CN1293654A Anti-tumour agents |
| 05/02/2001 | CN1293570A Pharmaceutical formulations for taxanes |
| 05/02/2001 | CN1293249A Human transmembrane glycosyl transport factor and its coding sequence |
| 05/02/2001 | CN1293248A Human shear and adenylation specific factor protein and its coding sequence |
| 05/02/2001 | CN1293247A Human zinc finger protein and its coding sequence |
| 05/02/2001 | CN1293207A Fusion protein with improved combining activity to target cell receptor |
| 05/02/2001 | CN1293205A Target-specific cytotoxin chimeric with short-peptide harmone |
| 05/02/2001 | CN1293202A Chimeric toxin including modified targeting part |
| 05/02/2001 | CN1293196A Dibenzylisoquinoline alkaloids and its preparing process and medicinal composition |
| 05/02/2001 | CN1293195A New polycyclicazaindole compound, its preparation method are medicine composition containing same |
| 05/02/2001 | CN1293042A Propolis honey and its preparing process |
| 05/02/2001 | CN1065240C Taxanes having butenyl substituted side-chain and pharmaceutical compositions containing them |
| 05/01/2001 | US6225494 Trisubstituted phenyl derivatives having retinoid agonist or inverse agonist type biological activity |
| 05/01/2001 | US6225457 Polynucleotide sequences associated with bacterial proteins; for detection of bactericides |
| 05/01/2001 | US6225455 Constructs for producing phosphorylated fusion proteins |
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225353 Method and composition for selectively inhibiting melanoma |
| 05/01/2001 | US6225340 Administering a dosage comprising 5-amino-2,2-dimethyl-6-(3'-(r,s) amino-4'-hydroxy-butan-1-one)-2,3-dihydro-4h-1-benzopyran-4-on e with carrier to inhibit arthritis |
| 05/01/2001 | US6225338 As antineoplastic agents and antioxidants |
| 05/01/2001 | US6225335 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease |
| 05/01/2001 | US6225328 Adamantyl-substituted retinoids and pharmaceutical/cosmetic compositions comprised thereof |
| 05/01/2001 | US6225325 Administering n-substituted-1,5-dideoxy-1,5-imino-d-glucitol or galactitol for prophylaxis, therapy, reducing, or reversing multidrug resistance in patient undergoing therapy with chemotherapeutic agent |
| 05/01/2001 | US6225323 Activated iododerivatives for the treatment of cancer and AIDS |
| 05/01/2001 | US6225322 4-(6,11-dihydro-5h-cyclohepta(2,1-b:4, 5-b')dipyridin-11-yl)-1-piperidinecarboxylic or sulfonic acid derivatives |
| 05/01/2001 | US6225320 Treatment of pain, inflammation, migraine, emesis and posttherpetic neuralgia |
| 05/01/2001 | US6225308 Tissue selective compounds in the treatment of prostate cancer or benign prostate hypertrophy |
| 05/01/2001 | US6225286 Cell surface protein expressed on human cortical thymocyte and their use |
| 05/01/2001 | US6225284 Somatostatin peptides |
| 05/01/2001 | US6225113 Genetically engineered vector for the transcription of heterologous genes in cells |
| 05/01/2001 | US6225098 UDP-N-acetylenolpyruvyglucosamine reductase |
| 05/01/2001 | US6225085 Nucleotide and amino acid sequence of leucine-rich surface glycoprotein; diagnosis; prophylaxis; therapy; drug screening; fusion proteins; antigenic peptides; antibodies; recombinant production |
| 05/01/2001 | US6225042 Culturing genetically engineered, antigen presenting insect cell line so that major histocompatibility class i molecules bound to selected peptide are produced on surface of cell, then contacting with cd8 t cells |
| 05/01/2001 | US6224912 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| 05/01/2001 | US6224883 Supplying to tumor, cancer |
| 05/01/2001 | US6224879 Genetic engineering |
| 05/01/2001 | US6224868 Reagent and processes for targeting mutant epidermal growth factor receptors |
| 05/01/2001 | US6224865 Suppression of inhibitors |
| 05/01/2001 | CA2195395C Cyclic hexapeptide somatostatin analogues |
| 05/01/2001 | CA2140624C P53 vaccine |
| 04/28/2001 | CA2324495A1 New 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro ¢3',4':6,7!-naphto ¢2,3-d! ¢1,3! dioxol-6(5ah)-one derivatives, their preparation process and pharmaceutical compositions containing them |
| 04/26/2001 | WO2001029564A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029233A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/26/2001 | WO2001029220A2 Mage-a12 antigenic peptides and uses thereof |
| 04/26/2001 | WO2001029218A2 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 04/26/2001 | WO2001029206A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/26/2001 | WO2001029199A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 04/26/2001 | WO2001029193A2 Cell constructs that are suitable for immunotherapy, the production and the use thereof |
| 04/26/2001 | WO2001029192A2 Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses |
| 04/26/2001 | WO2001029191A1 Method of in vitro culture of lymphocytes and gene therapy compositions |
| 04/26/2001 | WO2001029190A1 New lymphocytes, a process for preparing the same and their use in therapeutics |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029129A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/26/2001 | WO2001029084A2 Novel human proteins and polynucleotides encoding the same |
| 04/26/2001 | WO2001029079A1 IMMUNO-INTERACTIVE FRAGMENTS OF THE αC SUBUNIT OF INHIBIN |
| 04/26/2001 | WO2001029073A1 Methods for improving secondary metabolite production in fungi |
| 04/26/2001 | WO2001029057A1 Antisense modulation of bcl-6 expression |
| 04/26/2001 | WO2001029056A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | WO2001029049A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 04/26/2001 | WO2001029044A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/26/2001 | WO2001029043A1 Ucs1025 derivatives |
| 04/26/2001 | WO2001029042A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 04/26/2001 | WO2001029025A2 Tyrosine kinase inhibitors |
| 04/26/2001 | WO2001029023A1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 04/26/2001 | WO2001029009A1 4,5-disubstituted-2-aminopyrimidines |
| 04/26/2001 | WO2001029007A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 04/26/2001 | WO2001028993A2 Tyrosine kinase inhibitors |
| 04/26/2001 | WO2001028595A1 Cobalamin conjugates useful as imaging and therapeutic agents |
| 04/26/2001 | WO2001028594A2 Tumor detection by imaging and therapy of tumors |
| 04/26/2001 | WO2001028593A2 Conjugates useful in the treatment of prostate cancer |
| 04/26/2001 | WO2001028592A1 Cobalamin conjugates useful as imaging agents and as antitumor agents |
| 04/26/2001 | WO2001028587A2 Magnetic targeted carrier |
| 04/26/2001 | WO2001028585A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 04/26/2001 | WO2001028583A2 Melanoma vaccine and methods of making and using same |
| 04/26/2001 | WO2001028580A2 Modulation of angiogenesis |
| 04/26/2001 | WO2001028577A2 Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain |
| 04/26/2001 | WO2001028573A2 Monocyte conditioned medium for cancer treatment |
| 04/26/2001 | WO2001028557A1 Cannabimimetic indole derivatives |
| 04/26/2001 | WO2001028550A1 Topical anesthetics useful for treating cancer, autoimmune diseases and ischemia |
| 04/26/2001 | WO2001028521A2 Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate |
| 04/26/2001 | WO2001028498A2 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 04/26/2001 | WO2001028497A2 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 04/26/2001 | WO2001028494A2 Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 04/26/2001 | WO2001028492A2 Polyanhydrides with biologically active degradation products |
| 04/26/2001 | WO2001009129A3 1h-pirido[3, 4-b]indol-1-one derivatives |
| 04/26/2001 | WO2001006990A3 Use of etodolac to treat cancer |
| 04/26/2001 | WO2000077040A3 Human intracellular signaling molecules |
| 04/26/2001 | WO2000075121A3 Process for preparing 10,11-methanobenzosuberane derivatives |
| 04/26/2001 | WO2000071723A3 Methods for regulating protein conformation using molecular chaperones |
| 04/26/2001 | WO2000064486A3 Enzymatically activated polymeric drug conjugates |
| 04/26/2001 | WO2000063246A3 Compounds and methods for modulating beta-catenin mediated gene expression |
| 04/26/2001 | WO2000061612A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 04/26/2001 | WO2000061609B1 Prodrugs of thrombin inhibitors |
| 04/26/2001 | WO2000056889A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | WO2000047163A3 Use of hyaluronic acid or fragments thereof for regulating hematopoietic differentiation |